Read + Share
Amedeo Smart
Independent Medical Education
Popat S, Brustugun OT, Cadranel J, Felip E, et al. Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer. Lung Cancer 2021;157:9-16.PMID: 34051652
Email
LinkedIn
Facebook
Twitter
Privacy Policy